SynthesisMedicine2020

Effects of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on major adverse cardiovascular events in type 2 diabetes by race, ethnicity, and region: A meta-analysis.

Mei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.